Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Astellas appoints Peter Sandor as head of oncology

He joins the company from Amgen

- PMLiVE

AZ’s Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge

Roche Basel Switzerland

Roche exits four manufacturing sites with loss of 1,200 jobs

Closes three Europeans plants and one US facility

- PMLiVE

J&J and Hanmi collaborate on diabetes and obesity

Alliance worth up to$915m

- PMLiVE

Merck defeated in antibiotic patent case in US

Loses four patents protecting Cubicin from generic competition

- PMLiVE

Astellas adds to regenerative medicine unit with Ocata buy

Willpay around $379m for the cell therapy specialist

- PMLiVE

FDA approves Exelixis/Genentech’s melanoma combo Cotellic

Willprovide the first direct competition to Novartis' Mekinist in the US

Lucid’s motivation to make a difference in medical education drives everything they do

Changing lives with medical education

Lucid Group Communications Limited

WAE appoints new non-executive director

Tracey Barr to helpdrive growth in healthcare sector

Teva Pharma logo

TEVA’s tardive dyskinesia drug wins FDA breakthrough status

SD-809 to be given development incentives

Tragedy of the commons

Evolution suggests we need to be altruistic to our rivals

- PMLiVE

Amgen’s biosimilar shows clinical equivalence with Humira

ABP 501 as effective as AbbVie's blockbuster in phase III rheumatoid arthritis trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links